.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Teva
McKinsey
Queensland Health
Federal Trade Commission
Novartis
McKesson
Healthtrust
Cipla

Generated: July 26, 2017

DrugPatentWatch Database Preview

Metformin hydrochloride; repaglinide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for metformin hydrochloride; repaglinide and what is the scope of metformin hydrochloride; repaglinide freedom to operate?

Metformin hydrochloride; repaglinide
is the generic ingredient in two branded drugs marketed by Lupin Ltd and Novo Nordisk Inc, and is included in two NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are forty-eight drug master file entries for metformin hydrochloride; repaglinide. One supplier is listed for this compound.

Summary for Generic Name: metformin hydrochloride; repaglinide

Tradenames:2
Patents:1
Applicants:2
NDAs:2
Drug Master File Entries: see list48
Suppliers / Packagers: see list1
Clinical Trials: see list3,960
Drug Prices:see low prices
DailyMed Link:metformin hydrochloride; repaglinide at DailyMed

Pharmacology for Ingredient: metformin hydrochloride; repaglinide

Ingredient-typeBiguanides
Drug ClassBiguanide
Glinide
Mechanism of ActionPotassium Channel Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
REPAGLINIDE AND METFORMIN HYDROCHLORIDE
metformin hydrochloride; repaglinide
TABLET;ORAL200624-002Jul 15, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Novo Nordisk Inc
PRANDIMET
metformin hydrochloride; repaglinide
TABLET;ORAL022386-001Jun 23, 2008ABRXYesNo► Subscribe► Subscribe► Subscribe
Novo Nordisk Inc
PRANDIMET
metformin hydrochloride; repaglinide
TABLET;ORAL022386-002Jun 23, 2008ABRXYesYes► Subscribe► Subscribe► Subscribe
Lupin Ltd
REPAGLINIDE AND METFORMIN HYDROCHLORIDE
metformin hydrochloride; repaglinide
TABLET;ORAL200624-001Jul 15, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: metformin hydrochloride; repaglinide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novo Nordisk Inc
PRANDIMET
metformin hydrochloride; repaglinide
TABLET;ORAL022386-001Jun 23, 2008► Subscribe► Subscribe
Novo Nordisk Inc
PRANDIMET
metformin hydrochloride; repaglinide
TABLET;ORAL022386-002Jun 23, 2008► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
Covington
Johnson and Johnson
Novartis
Chinese Patent Office
Argus Health
Daiichi Sankyo
Dow
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot